Last 12 months
Inside the activity.
2 purchase rows · 112 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 26 |
| Jun 2026 | 0 | 13 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 56 |
| Sep 2026 | 0 | 12 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 05, 2021 Filed Sep 8, 2021 23:36 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
SaleCommon Stock | 1,000 | $386.03 | $386,030.00 |
DisclosureSEC source: 0001127602-21-025043 · form4.xml · nonDerivative · entry 1 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,111 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 20:41 UTC |
Dadswell CharlesSVP & General Counsel
|
SaleCommon Stock | 314 | $416.24 | $130,699.36 |
DisclosureSEC source: 0001127602-21-011925 · form4.xml · nonDerivative · entry 1 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,832 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| March 16, 2021 Filed Mar 18, 2021 23:20 UTC |
FLATLEY JAY TDirector
|
SaleCommon Stock | 4,000 | $421.06 | $1,684,240.00 |
DisclosureSEC source: 0001127602-21-011480 · form4.xml · nonDerivative · entry 1 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,933 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 22:29 UTC |
TOUSI SUSAN HSVP Product Development
|
SaleCommon Stock | 800 | $402.24 | $321,792.00 |
DisclosureSEC source: 0001127602-21-009917 · form4.xml · nonDerivative · entry 1 TOUSI SUSAN H · CIK 0001791938 · SVP Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,943 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 22:04 UTC |
FLATLEY JAY TDirector
|
SaleCommon Stock | 4,000 | $444.61 | $1,778,440.00 |
DisclosureSEC source: 0001127602-21-009435 · form4.xml · nonDerivative · entry 1 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,933 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 22:11 UTC |
MCGINNIS KAREN KVP, Chief Accounting Officer
|
SaleCommon Stock | 666 | $486.75 | $324,175.50 |
DisclosureSEC source: 0001127602-21-007081 · form4.xml · nonDerivative · entry 1 MCGINNIS KAREN K · CIK 0001188264 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,538 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:52 UTC |
TOUSI SUSAN HSVP Product Development
|
Exercise / conversionPerformance Shares · Derivative | 6,306 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006525 · form4.xml · derivative · entry 4 TOUSI SUSAN H · CIK 0001791938 · SVP Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,306 shares Expires 2021-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. F2 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:52 UTC |
TOUSI SUSAN HSVP Product Development
|
Tax withholdingCommon Stock | 3,178 | $494.24 | $1,570,694.72 |
DisclosureSEC source: 0001127602-21-006525 · form4.xml · nonDerivative · entry 3 TOUSI SUSAN H · CIK 0001791938 · SVP Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,743 Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:52 UTC |
TOUSI SUSAN HSVP Product Development
|
Exercise / conversionCommon Stock | 6,306 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006525 · form4.xml · nonDerivative · entry 2 TOUSI SUSAN H · CIK 0001791938 · SVP Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,921 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:52 UTC |
TOUSI SUSAN HSVP Product Development
|
GrantCommon Stock | 694 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006525 · form4.xml · nonDerivative · entry 1 TOUSI SUSAN H · CIK 0001791938 · SVP Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,615 F1 · shares: Represents additional shares of stock awarded as a result of the Company achieving at least 111% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:51 UTC |
SAMAD SAMSVP and CFO
|
Exercise / conversionPerformance Shares · Derivative | 4,379 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006524 · form4.xml · derivative · entry 4 SAMAD SAM · CIK 0001694295 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,379 shares Expires 2021-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. F2 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:51 UTC |
SAMAD SAMSVP and CFO
|
Tax withholdingCommon Stock | 2,170 | $494.24 | $1,072,500.80 |
DisclosureSEC source: 0001127602-21-006524 · form4.xml · nonDerivative · entry 3 SAMAD SAM · CIK 0001694295 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,185 Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:51 UTC |
SAMAD SAMSVP and CFO
|
Exercise / conversionCommon Stock | 4,379 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006524 · form4.xml · nonDerivative · entry 2 SAMAD SAM · CIK 0001694295 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,355 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:51 UTC |
SAMAD SAMSVP and CFO
|
GrantCommon Stock | 482 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006524 · form4.xml · nonDerivative · entry 1 SAMAD SAM · CIK 0001694295 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,976 F1 · shares: Represents additional shares of stock awarded as a result of the Company achieving at least 111% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:49 UTC |
RAGUSA ROBERT PSVP, Global Quality & Ops
|
Exercise / conversionPerformance Shares · Derivative | 6,306 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006523 · form4.xml · derivative · entry 4 RAGUSA ROBERT P · CIK 0001222644 · SVP, Global Quality & Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,306 shares Expires 2021-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. F2 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:49 UTC |
RAGUSA ROBERT PSVP, Global Quality & Ops
|
Tax withholdingCommon Stock | 3,178 | $494.24 | $1,570,694.72 |
DisclosureSEC source: 0001127602-21-006523 · form4.xml · nonDerivative · entry 3 RAGUSA ROBERT P · CIK 0001222644 · SVP, Global Quality & Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,617 Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:49 UTC |
RAGUSA ROBERT PSVP, Global Quality & Ops
|
Exercise / conversionCommon Stock | 6,306 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006523 · form4.xml · nonDerivative · entry 2 RAGUSA ROBERT P · CIK 0001222644 · SVP, Global Quality & Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,795 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:49 UTC |
RAGUSA ROBERT PSVP, Global Quality & Ops
|
GrantCommon Stock | 694 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006523 · form4.xml · nonDerivative · entry 1 RAGUSA ROBERT P · CIK 0001222644 · SVP, Global Quality & Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,489 F1 · shares: Represents additional shares of stock awarded as a result of the Company achieving at least 111% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:47 UTC |
MCGINNIS KAREN KVP, Chief Accounting Officer
|
Exercise / conversionPerformance Shares · Derivative | 935 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006520 · form4.xml · derivative · entry 4 MCGINNIS KAREN K · CIK 0001188264 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 935 shares Expires 2021-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. F2 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:47 UTC |
MCGINNIS KAREN KVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 372 | $494.24 | $183,857.28 |
DisclosureSEC source: 0001127602-21-006520 · form4.xml · nonDerivative · entry 3 MCGINNIS KAREN K · CIK 0001188264 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,204 Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:47 UTC |
MCGINNIS KAREN KVP, Chief Accounting Officer
|
Exercise / conversionCommon Stock | 935 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006520 · form4.xml · nonDerivative · entry 2 MCGINNIS KAREN K · CIK 0001188264 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,576 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:47 UTC |
MCGINNIS KAREN KVP, Chief Accounting Officer
|
GrantCommon Stock | 103 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006520 · form4.xml · nonDerivative · entry 1 MCGINNIS KAREN K · CIK 0001188264 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,641 F1 · shares: Represents additional shares of stock awarded as a result of the Company achieving at least 111% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:45 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
Exercise / conversionPerformance Shares · Derivative | 4,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006517 · form4.xml · derivative · entry 4 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,625 shares Expires 2021-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. F2 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:45 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
Tax withholdingCommon Stock | 1,762 | $494.24 | $870,850.88 |
DisclosureSEC source: 0001127602-21-006517 · form4.xml · nonDerivative · entry 3 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,111 Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:45 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
Exercise / conversionCommon Stock | 4,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006517 · form4.xml · nonDerivative · entry 2 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,873 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:45 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
GrantCommon Stock | 509 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006517 · form4.xml · nonDerivative · entry 1 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,248 F1 · shares: Represents additional shares of stock awarded as a result of the Company achieving at least 111% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:44 UTC |
Febbo Phillip G.SVP Chief Medical Officer
|
Exercise / conversionPerformance Shares · Derivative | 3,173 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006514 · form4.xml · derivative · entry 4 Febbo Phillip G. · CIK 0001649245 · SVP Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,173 shares Expires 2021-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. F2 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:44 UTC |
Febbo Phillip G.SVP Chief Medical Officer
|
Tax withholdingCommon Stock | 1,454 | $494.24 | $718,624.96 |
DisclosureSEC source: 0001127602-21-006514 · form4.xml · nonDerivative · entry 3 Febbo Phillip G. · CIK 0001649245 · SVP Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,592 Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:44 UTC |
Febbo Phillip G.SVP Chief Medical Officer
|
Exercise / conversionCommon Stock | 3,173 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006514 · form4.xml · nonDerivative · entry 2 Febbo Phillip G. · CIK 0001649245 · SVP Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,046 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:44 UTC |
Febbo Phillip G.SVP Chief Medical Officer
|
GrantCommon Stock | 350 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006514 · form4.xml · nonDerivative · entry 1 Febbo Phillip G. · CIK 0001649245 · SVP Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,873 F1 · shares: Represents additional shares of stock awarded as a result of the Company achieving at least 111% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:42 UTC |
deSouza Francis ADirector · President and CEO
|
Exercise / conversionPerformance Shares · Derivative | 24,521 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006511 · form4.xml · derivative · entry 4 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,521 shares Expires 2021-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. F2 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:42 UTC |
deSouza Francis ADirector · President and CEO
|
Tax withholdingCommon Stock | 13,194 | $494.24 | $6,521,002.56 |
DisclosureSEC source: 0001127602-21-006511 · form4.xml · nonDerivative · entry 3 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,740 Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:42 UTC |
deSouza Francis ADirector · President and CEO
|
Exercise / conversionCommon Stock | 24,521 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006511 · form4.xml · nonDerivative · entry 2 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,934 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:42 UTC |
deSouza Francis ADirector · President and CEO
|
GrantCommon Stock | 2,698 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006511 · form4.xml · nonDerivative · entry 1 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,413 F1 · shares: Represents additional shares of stock awarded as a result of the Company achieving at least 111% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:41 UTC |
Dadswell CharlesSVP & General Counsel
|
Exercise / conversionPerformance Shares · Derivative | 3,503 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006507 · form4.xml · derivative · entry 4 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,503 shares Expires 2021-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. F2 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:41 UTC |
Dadswell CharlesSVP & General Counsel
|
Tax withholdingCommon Stock | 1,635 | $494.24 | $808,082.40 |
DisclosureSEC source: 0001127602-21-006507 · form4.xml · nonDerivative · entry 3 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,146 Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:41 UTC |
Dadswell CharlesSVP & General Counsel
|
Exercise / conversionCommon Stock | 3,503 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006507 · form4.xml · nonDerivative · entry 2 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,781 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:41 UTC |
Dadswell CharlesSVP & General Counsel
|
GrantCommon Stock | 386 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006507 · form4.xml · nonDerivative · entry 1 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,278 F1 · shares: Represents additional shares of stock awarded as a result of the Company achieving at least 111% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017. Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 00:08 UTC |
FLATLEY JAY TDirector
|
SaleCommon Stock | 250 | $494.67 | $123,666.25 |
DisclosureSEC source: 0001127602-21-006557 · form4.xml · nonDerivative · entry 3 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Daughters Disclosed balance after: 3,500 Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 00:08 UTC |
FLATLEY JAY TDirector
|
SaleCommon Stock | 250 | $495.51 | $123,876.30 |
DisclosureSEC source: 0001127602-21-006557 · form4.xml · nonDerivative · entry 2 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Daughters Disclosed balance after: 3,750 Read SEC document |
| February 16, 2021 Filed Feb 19, 2021 00:08 UTC |
FLATLEY JAY TDirector
|
SaleCommon Stock | 4,000 | $505.26 | $2,021,040.00 |
DisclosureSEC source: 0001127602-21-006557 · form4.xml · nonDerivative · entry 1 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,933 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| February 10, 2021 Filed Feb 11, 2021 23:59 UTC |
deSouza Francis ADirector · President and CEO
|
GrantPerformance Shares · Derivative | 18,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005289 · form4.xml · derivative · entry 2 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,334 Underlying: Common Stock · 18,334 shares Expires 2023-12-31 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 31, 2023. The number of shares issued will range from 0% to 175% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 31,2023, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 31, 2023. The number of shares issued will range from 0% to 175% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 31,2023, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. Read SEC document |
| February 10, 2021 Filed Feb 11, 2021 23:59 UTC |
deSouza Francis ADirector · President and CEO
|
GrantCommon Stock | 6,112 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005289 · form4.xml · nonDerivative · entry 1 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,715 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2021, November 5, 2022, November 5, 2023, and November 5, 2024, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 23:58 UTC |
TOUSI SUSAN HSVP Product Development
|
GrantPerformance Shares · Derivative | 6,623 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005288 · form4.xml · derivative · entry 2 TOUSI SUSAN H · CIK 0001791938 · SVP Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,623 Underlying: Common Stock · 6,623 shares Expires 2023-12-31 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 31, 2023. The number of shares issued will range from 0% to 175% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 31,2023, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 31, 2023. The number of shares issued will range from 0% to 175% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 31,2023, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 23:58 UTC |
TOUSI SUSAN HSVP Product Development
|
GrantCommon Stock | 2,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005288 · form4.xml · nonDerivative · entry 1 TOUSI SUSAN H · CIK 0001791938 · SVP Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,921 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2021, November 5, 2022, November 5, 2023, and November 5, 2024, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 23:56 UTC |
SAMAD SAMSVP and CFO
|
GrantPerformance Shares · Derivative | 4,140 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005287 · form4.xml · derivative · entry 2 SAMAD SAM · CIK 0001694295 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,140 Underlying: Common Stock · 4,140 shares Expires 2023-12-31 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 31, 2023. The number of shares issued will range from 0% to 175% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 31,2023, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 31, 2023. The number of shares issued will range from 0% to 175% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 31,2023, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 23:56 UTC |
SAMAD SAMSVP and CFO
|
GrantCommon Stock | 1,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005287 · form4.xml · nonDerivative · entry 1 SAMAD SAM · CIK 0001694295 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,494 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2021, November 5, 2022, November 5, 2023, and November 5, 2024, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 23:54 UTC |
Reeves Kathryne GambrellSVP, Chief Marketing Officer
|
GrantPerformance Shares · Derivative | 4,140 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005286 · form4.xml · derivative · entry 2 Reeves Kathryne Gambrell · CIK 0001824170 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,140 Underlying: Common Stock · 4,140 shares Expires 2023-12-31 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 31, 2023. The number of shares issued will range from 0% to 175% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 31,2023, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 31, 2023. The number of shares issued will range from 0% to 175% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 31,2023, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 23:54 UTC |
Reeves Kathryne GambrellSVP, Chief Marketing Officer
|
GrantCommon Stock | 1,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005286 · form4.xml · nonDerivative · entry 1 Reeves Kathryne Gambrell · CIK 0001824170 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,567 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2021, November 5, 2022, November 5, 2023, and November 5, 2024, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 23:47 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
GrantPerformance Shares · Derivative | 4,140 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005284 · form4.xml · derivative · entry 2 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,140 Underlying: Common Stock · 4,140 shares Expires 2023-12-31 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 31, 2023. The number of shares issued will range from 0% to 175% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 31,2023, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 31, 2023. The number of shares issued will range from 0% to 175% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 31,2023, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.